AFG
HALO icon

Albion Financial Group’s Halozyme HALO Stock Holding History

Albion Financial Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04K Hold
26
– – ﹤0.01% 544
2026
Q1 		$1.68K Hold
26
– – ﹤0.01% 580
2025
Q4 		$1.75K Hold
26
– – ﹤0.01% 549
2025
Q3 		$1.91K Buy
+26
New +$1.73K ﹤0.01% 529

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Albion Financial Group's HALO Position: Q2 2026 in Review

Albion Financial Group held its Halozyme (HALO) position steady in Q2 2026 at 26 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Albion Financial Group first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Albion Financial Group held 26 shares of Halozyme worth $2.04K as of Q2 2026.
  • Albion Financial Group left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #544 holding.
  • Albion Financial Group first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.